Catch up on today’s top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she views Foot Locker as a “best-in-class” footwear retailer and sees an attractive entry point at current valuation levels. 2. Under Armour (UA, UAA) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss citing his meeting with management, including CEO Kevin Plank, and saying the clear tone from the top was “controlled confidence” in the brand direction with “disciplined” fiscal 2020 global top- and bottom-line growth acceleration. 3. Philip Morris (PM) upgraded to Neutral from Underperform at BofA/Merrill with analyst Lisa Lewandowski saying IQOS, the company’s heated tobacco product, is gaining traction in several European and Asian markets, the FDA approved the pre-market application for the sale of IQOS in the U.S., and management has reset IQOS commercialization expectations, among other reasons. 4. Walmart (WMT) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying he believes the company’s EBIT gains in the U.S. will continue. 5. United Therapeutics (UTHR) upgraded to Neutral from Sell at UBS with analyst Carter Gould saying that after a 26% stock price decline since late March, when Sandoz launched generic Remodulin, the risk reward on the stock has become more balanced. This list is just a portion of The Fly’s full analyst coverage. To see The Fly’s full Street Research coverage, (click here.):(http://thefly.com/streetResearch.php)
previous post
next post